Jon Weber
Senior Director, Cell & Amp Gene Therapy Market Access Lead Bayer
Jon Weber is a Global Market Access Cell & Gene Therapy Therapeutic Area Lead at Bayer. In this role, Jon is responsible for optimizing access for Bayer’s portfolio of Cell & Gene Therapies by developing and advancing innovative solutions for payers and healthcare systems. Prior to joining Bayer, Jon worked in a similar capacity as a Global Access Value and Evidence Strategy Lead at bluebird bio (Genetix Biotherapeutics) and consulted for Pharma/Biotech in many disease areas and treatment modalities while at Putnam Associates and Simon-Kucher & Partners. Jon earned a PhD in Pathology from the University of Rochester, an MBA from the Simon School of Business, and a BA in Biology from Colby College.
Seminars
- Designing clinical trials and programs with commercialization and patient access in mind from the start
- Defining the right target patient and unmet need to build a strong, scalable value proposition
- Maximizing long-term benefits by prioritizing early decisions on formulation, administration, and cost reduction
